Back to Search
HEATHER KRELL, M.D., M.P.H.
M.D., M.P.H.
Psychiatry Physician
NPI: 1386815496Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry Physician
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
G85426(CA)
Pain Medicine (Psychiatry & Neurology) Physician
Psychiatry & Neurology — Pain Medicine
Code: 2084P2900X
G85426(CA)
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
G85426(CA)
Research & Publications (20)
Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.
PMID 15367043·J Clin Psychiatry·2004
3-trial
A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability.
PMID 18630890·J Med Chem·2008
7-preclinical
Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
PMID 17875701·Cancer Res·2007
7-preclinical
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
PMID 16758188·Cancer Chemother Pharmacol·2007
7-preclinical
N-terminal proteolysis of the endothelin B receptor abolishes its ability to induce EGF receptor transactivation and contractile protein expression in vascular smooth muscle cells.
PMID 16601236·Arterioscler Thromb Vasc Biol·2006
7-preclinical
The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.
PMID 16516196·Exp Neurol·2006
4-observational
Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
PMID 16497166·Biol Chem·2006
8-other
BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
PMID 16254573·Cell Death Differ·2006
7-preclinical
Reduction of alachlor-induced olfactory mucosal neoplasms by the matrix metalloproteinase inhibitor Ro 28-2653.
PMID 16178123·Toxicol Pathol·2005
4-observational
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
PMID 16096433·Anticancer Drugs·2005
7-preclinical
Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
PMID 15277330·Circulation·2004
7-preclinical
Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
PMID 15217936·Clin Cancer Res·2004
7-preclinical
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
PMID 15075439·Neuromolecular Med·2004
7-preclinical
Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
PMID 14594449·Biochem J·2004
4-observational
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization.
PMID 14563686·FASEB J·2003
7-preclinical
Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone.
PMID 12963732·J Biol Chem·2003
7-preclinical
Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.
PMID 12518325·Prostate·2003
7-preclinical
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
PMID 12359766·Cancer Res·2002
7-preclinical
The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process.
PMID 12226103·J Biol Chem·2002
8-other
The novel synthetic inhibitor of matrix metalloproteinases Ro 28-2653 induces apoptosis in Dunning tumor cells.
PMID 11997665·Apoptosis·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 12100 WILSHIRE BLVD, SUITE 800
LOS ANGELES, CA 90025 - Phone
- (310) 428-8676
Quick Facts
- NPI
- 1386815496
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile